Clinical Trial Update: Effect of Sitagliptin in Impaired Glucose Tolerance [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update investigating the effects of sitagliptin in individuals with impaired glucose tolerance.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Impaired Glucose Tolerance

Drugs mentioned

• Sitagliptin (sitagliptin)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Impaired Glucose Tolerance | Phase 2 | Status: UNKNOWN